LIVE: Reuters Newsmaker with Lars Fruergaard Jørgensen, CEO of Novo Nordisk

  Рет қаралды 3,643

Reuters

Reuters

Күн бұрын

Novo Nordisk is the first drugmaker to introduce a highly effective weight-loss drug, Wegovy, at a time of record obesity rates.
Lars Fruergaard Jørgensen, CEO of Novo Nordisk, discusses with Reuters Breakingviews columnist Aimee Donnellan the challenge of rapidly ramping up production of Wegovy to meet soaring demand for the breakthrough drug.

#LarsFruergaardJørgensen #NovoNordisk #Wegovy AimeeDonnellan #ReutersNewsmaker #Reuters #Live #News #business #finance

Пікірлер
CEO DIALOGUE #35 - Lars Fruergaard Jørgensen, Novo Nordisk
49:08
Institute for Management Development IMD
Рет қаралды 1,1 М.
😜 #aminkavitaminka #aminokka #аминкавитаминка
00:14
Аминка Витаминка
Рет қаралды 2,6 МЛН
CAN YOU DO THIS ?
00:23
STORROR
Рет қаралды 47 МЛН
The Billion Dollar Scam - BBC World Service Documentaries
47:11
BBC World Service
Рет қаралды 6 МЛН
The CEO Behind Ozempic, Wegovy and Europe's Most Valuable Company
24:07
Bloomberg Television
Рет қаралды 6 М.
Poverty in America is by design w/Matthew Desmond | The Chris Hedges Report
31:44
The Real News Network
Рет қаралды 563 М.
Satya Nadella, CEO of Microsoft
54:16
Stanford Graduate School of Business
Рет қаралды 1,4 МЛН
😜 #aminkavitaminka #aminokka #аминкавитаминка
00:14
Аминка Витаминка
Рет қаралды 2,6 МЛН